As the new year sparks a wave of weight loss resolutions and millions turn to weight loss medications, rising costs and the ...
President-elect Donald Trump’s threat to slap Denmark with tariffs to force its hand in giving up Greenland could lead to ...
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...
Diet food brands have been hit in recent years, but now GLP-1 drugs like Ozempic are hitting the market, will this spell the ...
Britain's Terry Smith made public for the first time on Thursday why his fund dumped its Diageo stake last year, citing ...
LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...
Grapefruit contains vitamin C, a powerful antioxidant that can boost the immune system. Dietitians share health benefits and ...
Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on ...
PGC-1α research offers new hope for weight loss by boosting metabolic efficiency and providing accessible management ...
The drug's development was funded by Novo Nordisk, the maker of popular semaglutide drugs like Ozempic and Wegovy. While these GLP-1 receptor agonists are effective in weight management, they often ...
Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...
Polls provide a useful window into understanding how Americans view their own weight and the recent availability of drugs ...